Yubo International Biotech Ltd
YBGJ· OTC
YBGJYubo International Biotech Ltd
Filed Apr 12, 2024 · 10-K · 103 days after period end · 0001640334-24-000618
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 |
|---|---|---|---|---|
| Revenue | $18.12K | $66.52K | — | — |
| Net Income | -$517.38K | $103.61K | -$397.17K | -$438.68K |
| EPS Diluted | — | — |
Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR
| — |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2023 · filed Apr 12, 2024 · 103 d after period end
